pd 153035 has been researched along with Mouth Neoplasms in 1 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral squamous cell carcinoma (OSCC) is the sixth most common human neoplasm worldwide." | 1.38 | Therapeutic and preventive effects of an epidermal growth factor receptor inhibitor on oral squamous cell carcinoma. ( Fu, Z; Ge, H; Liu, H; Sun, Z, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, H | 1 |
| Liu, H | 1 |
| Fu, Z | 1 |
| Sun, Z | 1 |
1 other study available for pd 153035 and Mouth Neoplasms
| Article | Year |
|---|---|
Therapeutic and preventive effects of an epidermal growth factor receptor inhibitor on oral squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis | 2012 |